Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Crawford

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Drugs|December 14, 2002
Pegfilgrastim administered once per cycle reduces incidence of chemotherapy-induced neutropeniaJeffrey Crawford
Clinical Advances in Hematology & Oncology : H&O|February 13, 2014
Prevention and treatment of chemotherapy-induced neutropeniaJeffrey Crawford
Seminars in Oncology|September 26, 2003
Once-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropeniaJeffrey Crawford
The Journal of Supportive Oncology|August 20, 2005
Improving the management of chemotherapy-induced neutropeniaJeffrey Crawford
Oncology (Williston Park, N.Y.)|August 24, 2006
Erythropoiesis-stimulating protein support and survivalJeffrey Crawford
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Moving forward with myeloid growth factorsJeffrey Crawford
Supportive Cancer Therapy|July 17, 2008
Expanding the horizons of supportive therapyJeffrey Crawford
Supportive Cancer Therapy|July 17, 2008
Improving clinical practice: the importance of guideline developmentJeffrey Crawford
Supportive Cancer Therapy|July 17, 2008
Impact of the multinational association of supportive care in cancer on supportive cancer therapyJeffrey Crawford
The Journal of Supportive Oncology|June 7, 2007
Update on neutropenia and myeloid growth factorsJeffrey Crawford
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Drugs|December 14, 2002
Pegfilgrastim administered once per cycle reduces incidence of chemotherapy-induced neutropeniaJeffrey Crawford
Clinical Advances in Hematology & Oncology : H&O|February 13, 2014
Prevention and treatment of chemotherapy-induced neutropeniaJeffrey Crawford
Seminars in Oncology|September 26, 2003
Once-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropeniaJeffrey Crawford
The Journal of Supportive Oncology|August 20, 2005
Improving the management of chemotherapy-induced neutropeniaJeffrey Crawford
Oncology (Williston Park, N.Y.)|August 24, 2006
Erythropoiesis-stimulating protein support and survivalJeffrey Crawford
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Moving forward with myeloid growth factorsJeffrey Crawford
Supportive Cancer Therapy|July 17, 2008
Expanding the horizons of supportive therapyJeffrey Crawford
Supportive Cancer Therapy|July 17, 2008
Improving clinical practice: the importance of guideline developmentJeffrey Crawford
Supportive Cancer Therapy|July 17, 2008
Impact of the multinational association of supportive care in cancer on supportive cancer therapyJeffrey Crawford
The Journal of Supportive Oncology|June 7, 2007
Update on neutropenia and myeloid growth factorsJeffrey Crawford
Pageof 20